VI.2 Elements for a public summary

Share "VI.2 Elements for a public summary"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "VI.2 Elements for a public summary"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 7 páginas )

Texto

Referências

Descarregar agora ( PDF - 7 páginas - 70.66 KB )

Documentos relacionados

Guidance on format of the RMP in the EU for Generics

Risk What is known including reason why it is considered a potential risk osteopenia and loss of bone density osteoporosis patients should talk to their doctor, pharmacist, or nurse

Documentos relacionados

VI.2 Elements for a Public Summary

,with the World Health Organisation (WHO) estimating that depression affects 350 million people with the burden 50% higher for females than males.

PDF VI.2 Elements for a public summary VI.2.1 ... - Lægemiddelstyrelsen

PDF VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology

VI.2 Elements for a Public Summary

Bendamustine is used alone (monotherapy) or in combination with other medicines for the treatment of patients with

VI.2 Elements for a Public Summary